Compare McCormick & Company, Incorporated (MKC) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McCormick & Company, Incorporated vs DENTSPLY SIRONA Inc — how do they compare? McCormick & Company, Incorporated trades at $44.81 (market cap $12.39B), while DENTSPLY SIRONA Inc trades at $8.83 (market cap $1.73B). The key difference: McCormick & Company, Incorporated is far larger — about 7.2× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays the higher dividend (5.04%). Which is the better fit depends on your goals — on Pluang, investors hold McCormick & Company, Incorporated for 67 Days and DENTSPLY SIRONA Inc for 72 Days on average.
| MKC | XRAY | |
|---|---|---|
Market Cap | $12.39B | $1.73B |
Volume | 6,140,872 | 6,198,582 |
Sector | Consumer Staples | Health |
52-Week High | $71.65 | $14.68 |
52-Week Low | $44.14 | $8.52 |
Typical Hold Time | 67 Days | 72 Days |
Enterprise Value | $17.07B | $3.80B |
Dividend Yield | 4.18% | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McCormick & Company (MKC) trades at $45.94, showing modest daily gains of 1.52%. The stock presents a mixed technical picture with bearish moving averages but neutral oscillators, while fundamentally it maintains strong profitability with 19.39% net income margin and attractive valuation at 8.31 P/E. Recent Q3 2026 earnings beat expectations with $0.86 EPS, driven by 17% sales growth and margin expansion from the Mexico acquisition.
MKC offers value with discounted valuation and dividend yield, but faces technical headwinds and competitive pressures. The consensus price target of $53.50 suggests 16% upside potential, though analyst sentiment remains cautious with 60% hold ratings. Key risks include integration challenges from acquisitions and consumer spending sensitivity.
DENTSPLY SIRONA (XRAY) trades at $8.69, near its 52-week low, with a bearish technical signal from moving averages. The company reported a Q2 2026 earnings beat but faces declining revenue and negative net income margins. Recent news highlights institutional stake increases and ongoing restructuring efforts amid weak dental market conditions.
The outlook remains challenging with persistent profitability issues and high debt levels, though analyst consensus suggests upside potential with a $13 price target. Key risks include margin pressure and competitive threats, requiring careful monitoring of the company's turnaround execution for any recovery signs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About McCormick & Company, Incorporated
In its 130-year history, McCormick has grown to become the leading global manufacturer, marketer, and distributor of spices, herbs, extracts, seasonings, and other flavorings. Beyond end consumers, McCormick's customer base also includes top quick-service restaurants, retail grocery chains, and other packaged food and beverage manufacturers, with about 30% of sales generated beyond its home turf to include 150 other countries and territories. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and the recently acquired Cholula brand.
Read more on MKC →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
